News
This is How to Beat the Tumor Cells That Survive Cancer Therapy
Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These “persister” cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment. The problem is, persister cells are rare — as few as one in a thousand tumor cells — and they’re
New CRISPR Technique Selectively Shreds Cancer Cells, Including “Undruggable” Cancers
The job of a tumor suppressor protein is right in the name: stopping us from getting cancer at the cellular level. But when they’re not working properly, the cell is left with limited defenses. In a new paper published today in the journal Nature titled “Targeting Cancer-Specific Mutations with RNA
How Big Tobacco Helped Shape the Design of Ultra-Processed Foods
A new UC San Francisco study reveals how Philip Morris Companies Inc. used cigarette research, flavor engineering, and behavioral science to turn Lunchables into one of America’s most successful ultra-processed foods for children. When Phillip Morris acquired General Foods in 1985, it inherited
How New AI Cuts Breast Cancer Screening Time for High-Risk Women
Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer. Now, researchers at UC San Francisco and UC Berkeley have found a way to help reduce the wait and the worry by using artificial intelligence (AI) to quickly identify those who are most likely to
Targeted Therapies, Improved Breast Cancer Screening Among Conference Presentations
Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29 to June 2 in Chicago. Leading UCSF cancer researchers will present talks about advances in
Uncovering the Hidden Drivers Behind Rising Cancer Rates in Asian American Communities
Cancer has long been the leading cause of death for many Asian American communities, yet important differences in cancer risk across Asian ethnic groups are often overlooked. Researchers leading the Greater Bay Area Cancer Registry are working to better understand these disparities — including
Walk to End Bladder Cancer Raises $120K and Lights Up City Hall
San Francisco City Hall was illuminated in orange on May 9, 2026, in recognition of Bladder Cancer Awareness Month and the city’s inaugural in-person Walk to End Bladder Cancer, a milestone reflecting the strength and leadership of UCSF’s nationally recognized bladder cancer program. Mayor Daniel